Cargando…

Early triple antiviral therapy for COVID-19

Detalles Bibliográficos
Autores principales:	Lee, Nelson, Ison, Michael, Dunning, Jake
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836694/ https://www.ncbi.nlm.nih.gov/pubmed/33160566 http://dx.doi.org/10.1016/S0140-6736(20)32274-1

Ejemplares similares

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

Antiviral pills: A potential game-changing therapy against COVID-19
por: Dhawan, Manish, et al.
Publicado: (2022)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
por: Hübner, Yannis R., et al.
Publicado: (2023)

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Functional exhaustion of antiviral lymphocytes in COVID-19 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
por: Boretti, Alberto
Publicado: (2023)

Randomised controlled trials for mpox in endemic countries
por: Rojek, Amanda, et al.
Publicado: (2023)

Antiviral Treatments
por: Ison, Michael G.
Publicado: (2017)

Prospective role of NSAIDs with antiviral properties for pharmacological management of postsurgical procedures during COVID-19
por: Nainu, Firzan, et al.
Publicado: (2023)

Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection
por: Wada, Daiki, et al.
Publicado: (2022)

Direct-acting antivirals for acute hepatitis C in HIV-infected MSM
por: Millard, James Daniel, et al.
Publicado: (2016)

Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?
por: Sun, Xishi, et al.
Publicado: (2021)

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
por: Read, Jonathan M, et al.
Publicado: (2021)

Early Detection and Therapy Is the Key for the Management of Type A Aortic Dissection With COVID-19: Reply
por: Fukuhara, Shinichi
Publicado: (2021)

Antiviral effects of oleandrin
por: Newman, R., et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

Antiviral combinations for severe influenza
por: Dunning, Jake, et al.
Publicado: (2014)

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021)

Plasma P‐selectin is an early marker of thromboembolism in COVID‐19
por: Fenyves, Bánk G., et al.
Publicado: (2021)

Severe Hypoxemia in Early COVID-19 Pneumonia
por: Bhatia, Pradeep, et al.
Publicado: (2020)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform
por: Chu, Helen Y., et al.
Publicado: (2020)

Simultaneous Triple Microbial Keratitis
por: Jun, Jong Hwa
Publicado: (2019)

Brazil's COVID-19 response
por: Rizzo, Luiz Vicente, et al.
Publicado: (2020)

Impact of early COVID-19-related challenges on pediatric researchers: an exploratory analysis
por: Shah, Shetal, et al.
Publicado: (2023)

The Imperative of Early Treatment for Children With COVID-19 Infection
por: Elenga, Narcisse
Publicado: (2020)

Is termination of early pregnancy indicated in women with COVID-19?
por: Wu, Yan-Ting, et al.
Publicado: (2020)

Casirivimab - Imdevimab in Covid 19 – Early Indian experience
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2022)

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lvl7nrpeae6da9ah8nitjhapqs